More than a brand: Strategic botulinum toxin decisions

Botulinum toxin products are used across a wide range of therapeutic indications, yet many health systems have not evaluated whether product selection aligns with both clinical evidence and financial stewardship. Matt Groth, Director of Pharmacy and Pharmaceutical Supply Chain Management at the University of Rochester Medical Center, joins Kerry Schwarz to discuss how his team implemented a botulinum toxin stewardship strategy by evaluating evidence, engaging clinicians, and standardizing product selection.   Guest Speaker: Matthew D. Groth, PharmD, MS Director of Pharmacy Pharmaceutical Supply Chain Management University of Rochester Medical Center   Host: Dr. Kerry Schwarz, Pharm.D., MPH Senior Clinical Manager, Evidence-Based Medicine and Outcomes Vizient Center for Pharmacy Practice Excellence    Show Notes:  00:05 Introduction Learn why botulinum toxin stewardship is an emerging opportunity for health systems. Hear how clinical evidence and financial strategy can work together to optimize product selection. 01:25 Reviewing the evidence Explore the evidence supporting available botulinum toxin products, including indications, safety, and dosing considerations. Understand why limited clinical differences between products create opportunities for formulary evaluation. 02:31 Identifying stewardship opportunities Learn how organizations evaluate acquisition costs, reimbursement, payer policies, and contracting opportunities. Discover how financial analysis helps identify opportunities to reduce costs while maintaining quality patient care. 04:29 Implementing a preferred product strategy Hear how provider engagement, financial transparency, and P&T committee support helped drive adoption. Learn how a phased implementation approach increased market share while improving financial performance. 08:11 Lessons learned from implementation Explore the operational considerations that support successful implementation, from inventory management to prior authorizations. Learning why collaboration with physicians, nurses, office staff, and billing teams is essential to long term success. 10:57 Key takeaways Review the core elements of a successful botulinum toxin stewardship strategy. Learn how multidisciplinary collaboration can improve value while maintaining high quality patient care.   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed